Neuroscientists Discover Sleep-Like Brain Activity Under Mental Fatigue

Summary: A multidisciplinary study by researchers at the IMT School of Advanced Studies Lucca has found that prolonged mental fatigue can trigger a phenomenon known as “local sleep,” where parts of the brain display sleep-like activity even while awake. This mental exhaustion, linked to the concept of “ego depletion,” reduces self-control, leading to more aggressive…

Read More

Research Backs ‘Folklore’ Suggesting Cannabis Compound Helps with Sleep

Summary: Researchers at the University of Sydney have provided objective evidence that cannabinol (CBN), a compound found in aged cannabis, improves sleep quality in rats. For decades, it was believed that aged cannabis induces sleepiness due to CBN buildup, but until now, this claim lacked scientific validation. The study showed that CBN increased both deep…

Read More

Teens Who Sleep Well Show 37% Lower Risk of High Blood Pressure

Summary: A study by UTHealth Houston found that adolescents who meet the recommended sleep duration of 9-11 hours per night have a significantly lower risk of developing high blood pressure. Using data from the Adolescent Brain Cognitive Development study, researchers analyzed sleep patterns and blood pressure in over 3,300 teens. The findings revealed that consistent,…

Read More

BRPT to Launch New CRM Platform to Enhance Credential Holder Support

Summary: The Board of Registered Polysomnographic Technologists (BRPT) is transitioning to a new customer relationship management (CRM) platform on Nov 14 to enhance support for its credential holders. The new system will streamline processes such as secure payments, direct communication, and exam tracking, as well as provide personalized dashboards to reduce administrative burdens for exam…

Read More

Investigational Neurostimulator for OSA Cuts AHI By 66%

Summary: LivaNova announced positive results from its OSPREY clinical trial, showing that its investigational aura6000 hypoglossal nerve stimulator significantly reduces the severity of obstructive sleep apnea (OSA) after six months of therapy. The study met its primary safety and efficacy endpoints, with a 66% reduction in apnea-hypopnea index (AHI) and a 63% decrease in oxygen…

Read More

Virtual Primary Care Provider Partners with Aeroflow to Expand DME Access

Summary: HealthTap, a virtual primary care provider, is entering the durable medical equipment (DME) market by partnering with Aeroflow Health. This collaboration will allow Aeroflow customers without a primary care provider to access HealthTap’s virtual physicians for consultations, DME prescriptions, and ongoing health support, with a focus on improving patient access to comprehensive care. Key…

Read More

Avadel’s Narcolepsy Treatment Lumryz Brings in $50 Million in Q3

Summary: Avadel Pharmaceuticals reported strong third-quarter results, generating $50 million in revenue from its narcolepsy treatment Lumryz. The company recently received FDA approval to expand Lumryz use to pediatric patients, secured a favorable court ruling affirming the treatment’s clinical superiority over twice-nightly oxybate products, and continued progress in its Phase 3 trial for idiopathic hypersomnia.…

Read More